PropertyValue
?:abstract
  • Since the outset of the COVID-19 pandemic, numerous risk factors for severe disease have been identified. Whether patients with rheumatic diseases, especially those receiving DMARDs, are at an increased risk of SARS-CoV-2 infection or severe COVID-19 disease remains unclear, although epidemiological studies are providing some insight.
is ?:annotates of
?:creator
?:doi
  • 10.1038/s41584-020-00562-2
?:doi
?:journal
  • Nat_Rev_Rheumatol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/dc33b20566d9a5468d6a2d117f6780d33ba3105d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7747184.xml.json
?:pmcid
?:pmid
?:pmid
  • 33339986.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Rheumatic disease and COVID-19: epidemiology and outcomes
?:type
?:year
  • 2020-12-18

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/7p72g8o0>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/7p72g8o0>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all